| 0 |
ELECTROCARDIOGRAM RR INTERVAL ABNORMAL |
1 |
0.3333 |
| 1 |
REDUCED PARASYMPATHETIC ACTIVITY |
1 |
0.1667 |
| 2 |
ELECTROCARDIOGRAM J WAVE INCREASED |
1 |
0.1000 |
| 3 |
BILE CAST NEPHROPATHY |
2 |
0.0645 |
| 4 |
DELAYED ISCHAEMIC NEUROLOGICAL DEFICIT |
1 |
0.0476 |
| 5 |
ELECTROCARDIOGRAM RR INTERVAL PROLONGED |
2 |
0.0444 |
| 6 |
ARRHYTHMIC STORM |
11 |
0.0329 |
| 7 |
DEVICE PACING ISSUE |
2 |
0.0235 |
| 8 |
MULTI-VITAMIN DEFICIENCY |
1 |
0.0233 |
| 9 |
ACQUIRED LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION |
1 |
0.0204 |
| 10 |
CARBOXYHAEMOGLOBIN INCREASED |
1 |
0.0167 |
| 11 |
CARDIAC INDEX DECREASED |
1 |
0.0097 |
| 12 |
VENTRICULAR DYSSYNCHRONY |
1 |
0.0090 |
| 13 |
BLOOD METHAEMOGLOBIN PRESENT |
1 |
0.0090 |
| 14 |
GALLBLADDER RUPTURE |
4 |
0.0086 |
| 15 |
ACHROMOBACTER INFECTION |
1 |
0.0083 |
| 16 |
NODAL ARRHYTHMIA |
7 |
0.0081 |
| 17 |
NECROTISING OESOPHAGITIS |
4 |
0.0080 |
| 18 |
PNEUMONIA ACINETOBACTER |
1 |
0.0073 |
| 19 |
HYPOTENSIVE CRISIS |
1 |
0.0069 |
| 20 |
PERITONEAL HAEMATOMA |
1 |
0.0067 |
| 21 |
LOCAL ANAESTHETIC SYSTEMIC TOXICITY |
7 |
0.0066 |
| 22 |
MITOCHONDRIAL TOXICITY |
5 |
0.0061 |
| 23 |
ACUTE RIGHT VENTRICULAR FAILURE |
1 |
0.0059 |
| 24 |
BASE EXCESS DECREASED |
1 |
0.0056 |
| 25 |
FLOPPY INFANT |
1 |
0.0054 |
| 26 |
ELECTROCARDIOGRAM QRS COMPLEX SHORTENED |
2 |
0.0052 |
| 27 |
TORSADE DE POINTES |
40 |
0.0051 |
| 28 |
NORMOCHROMIC ANAEMIA |
1 |
0.0050 |
| 29 |
HAEMOPERITONEUM |
4 |
0.0050 |
| 30 |
ACUTE CHOLECYSTITIS NECROTIC |
1 |
0.0050 |
| 31 |
SKULL FRACTURED BASE |
1 |
0.0040 |
| 32 |
APNOEA NEONATAL |
1 |
0.0039 |
| 33 |
HYPOPERFUSION |
4 |
0.0038 |
| 34 |
LONG QT SYNDROME |
8 |
0.0033 |
| 35 |
FUNGAL ENDOCARDITIS |
1 |
0.0033 |
| 36 |
HEPATIC ISCHAEMIA |
1 |
0.0032 |
| 37 |
ANTICOAGULATION DRUG LEVEL INCREASED |
1 |
0.0031 |
| 38 |
PNEUMONITIS ASPIRATION |
1 |
0.0029 |
| 39 |
HEART TRANSPLANT REJECTION |
3 |
0.0029 |
| 40 |
ATRIAL TACHYCARDIA |
6 |
0.0029 |
| 41 |
PROPOFOL INFUSION SYNDROME |
2 |
0.0028 |
| 42 |
CEREBRAL ARTERY OCCLUSION |
3 |
0.0028 |
| 43 |
RESPIRATORY GAS EXCHANGE DISORDER |
1 |
0.0027 |
| 44 |
ALKALOSIS |
1 |
0.0026 |
| 45 |
REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME |
5 |
0.0025 |
| 46 |
SPINAL CORD HAEMORRHAGE |
1 |
0.0025 |
| 47 |
HAEMOBILIA |
1 |
0.0024 |
| 48 |
PSEUDOMONAL BACTERAEMIA |
2 |
0.0023 |
| 49 |
SPINAL CORD INFARCTION |
1 |
0.0023 |
| 50 |
STRESS CARDIOMYOPATHY |
13 |
0.0022 |
| 51 |
CLONUS |
6 |
0.0022 |
| 52 |
BRASH SYNDROME |
3 |
0.0021 |
| 53 |
WOLFF-PARKINSON-WHITE SYNDROME |
1 |
0.0021 |
| 54 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
3 |
0.0021 |
| 55 |
HEMIANOPIA |
2 |
0.0020 |
| 56 |
TACHYCARDIA FOETAL |
1 |
0.0020 |
| 57 |
GINGIVAL HYPERTROPHY |
3 |
0.0020 |
| 58 |
VENTRICULAR FIBRILLATION |
21 |
0.0019 |
| 59 |
ATRIOVENTRICULAR BLOCK COMPLETE |
12 |
0.0018 |
| 60 |
ARTERIOSPASM CORONARY |
7 |
0.0017 |
| 61 |
PO2 DECREASED |
2 |
0.0017 |
| 62 |
SICK SINUS SYNDROME |
2 |
0.0017 |
| 63 |
CHEMICAL BURN |
2 |
0.0017 |
| 64 |
NEPHROGENIC DIABETES INSIPIDUS |
2 |
0.0017 |
| 65 |
ACUTE LUNG INJURY |
2 |
0.0017 |
| 66 |
SINUS NODE DYSFUNCTION |
3 |
0.0016 |
| 67 |
VENTRICULAR TACHYCARDIA |
27 |
0.0016 |
| 68 |
ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC |
1 |
0.0015 |
| 69 |
CARDIOGENIC SHOCK |
21 |
0.0015 |
| 70 |
TOXIC EPIDERMAL NECROLYSIS |
22 |
0.0014 |
| 71 |
PRODUCT EXPIRATION DATE ISSUE |
2 |
0.0014 |
| 72 |
PCO2 INCREASED |
1 |
0.0014 |
| 73 |
PRODUCT DESIGN ISSUE |
1 |
0.0014 |
| 74 |
NODAL RHYTHM |
2 |
0.0014 |
| 75 |
HAEMORRHAGIC TRANSFORMATION STROKE |
2 |
0.0013 |
| 76 |
MULTIPLE DRUG THERAPY |
1 |
0.0013 |
| 77 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
4 |
0.0013 |
| 78 |
ATRIOVENTRICULAR BLOCK |
10 |
0.0013 |
| 79 |
SINUS ARREST |
2 |
0.0013 |
| 80 |
BLOOD FIBRINOGEN INCREASED |
1 |
0.0013 |
| 81 |
IMMUNE-MEDIATED MYOCARDITIS |
2 |
0.0012 |
| 82 |
VASOPLEGIA SYNDROME |
2 |
0.0012 |
| 83 |
SUPRAVENTRICULAR EXTRASYSTOLES |
4 |
0.0012 |
| 84 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
6 |
0.0012 |
| 85 |
VASOCONSTRICTION |
1 |
0.0011 |
| 86 |
CARDIAC OUTPUT DECREASED |
1 |
0.0011 |
| 87 |
BRADYPNOEA |
3 |
0.0011 |
| 88 |
CONDUCTION DISORDER |
2 |
0.0011 |
| 89 |
DRUG LEVEL ABOVE THERAPEUTIC |
5 |
0.0011 |
| 90 |
DISORGANISED SPEECH |
2 |
0.0011 |
| 91 |
PRODUCT APPEARANCE CONFUSION |
1 |
0.0011 |
| 92 |
NECK MASS |
3 |
0.0011 |
| 93 |
SINUS BRADYCARDIA |
10 |
0.0010 |
| 94 |
ULNA FRACTURE |
1 |
0.0010 |
| 95 |
BLADDER CANCER RECURRENT |
1 |
0.0010 |
| 96 |
VENTRICULAR EXTRASYSTOLES |
10 |
0.0010 |
| 97 |
INSULIN RESISTANCE |
2 |
0.0010 |
| 98 |
PULSELESS ELECTRICAL ACTIVITY |
4 |
0.0010 |
| 99 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
3 |
0.0009 |
| 100 |
LIP DISCOLOURATION |
1 |
0.0008 |
| 101 |
WEIGHT LOSS POOR |
4 |
0.0008 |
| 102 |
TONIC CLONIC MOVEMENTS |
1 |
0.0008 |
| 103 |
DRUG CLEARANCE DECREASED |
1 |
0.0008 |
| 104 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
2 |
0.0008 |
| 105 |
THROMBOCYTOPENIC PURPURA |
1 |
0.0007 |
| 106 |
ISCHAEMIC HEPATITIS |
1 |
0.0007 |
| 107 |
ECHOCARDIOGRAM ABNORMAL |
1 |
0.0007 |
| 108 |
ANTIPSYCHOTIC DRUG LEVEL INCREASED |
2 |
0.0007 |
| 109 |
BUNDLE BRANCH BLOCK LEFT |
3 |
0.0007 |
| 110 |
ELECTROCARDIOGRAM QT PROLONGED |
25 |
0.0007 |
| 111 |
CARDIOTOXICITY |
6 |
0.0007 |
| 112 |
HYPERTHERMIA MALIGNANT |
1 |
0.0007 |
| 113 |
PNEUMONIA PSEUDOMONAL |
1 |
0.0007 |
| 114 |
SUDDEN CARDIAC DEATH |
2 |
0.0006 |
| 115 |
BLOOD PH DECREASED |
1 |
0.0006 |
| 116 |
PUPIL FIXED |
1 |
0.0006 |
| 117 |
VENTRICULAR ARRHYTHMIA |
2 |
0.0005 |
| 118 |
TUNNEL VISION |
1 |
0.0005 |
| 119 |
ACIDOSIS |
4 |
0.0005 |
| 120 |
PNEUMONIA FUNGAL |
2 |
0.0005 |
| 121 |
POLYDIPSIA |
2 |
0.0005 |
| 122 |
RENAL HAEMORRHAGE |
1 |
0.0005 |
| 123 |
OLIGURIA |
3 |
0.0005 |
| 124 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
2 |
0.0005 |
| 125 |
BUNDLE BRANCH BLOCK RIGHT |
2 |
0.0004 |
| 126 |
ISCHAEMIA |
2 |
0.0004 |
| 127 |
SINUS TACHYCARDIA |
6 |
0.0004 |
| 128 |
RADIUS FRACTURE |
1 |
0.0004 |
| 129 |
PRODUCT PACKAGING CONFUSION |
1 |
0.0004 |
| 130 |
BRONCHITIS CHRONIC |
1 |
0.0004 |
| 131 |
TRANSPLANT FAILURE |
1 |
0.0004 |
| 132 |
EXPIRED DRUG ADMINISTERED |
2 |
0.0004 |
| 133 |
TACHYARRHYTHMIA |
1 |
0.0004 |
| 134 |
CATHETER SITE HAEMORRHAGE |
1 |
0.0004 |
| 135 |
VASODILATATION |
1 |
0.0004 |
| 136 |
HAEMODYNAMIC INSTABILITY |
3 |
0.0004 |
| 137 |
SEDATION COMPLICATION |
1 |
0.0004 |
| 138 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
1 |
0.0004 |
| 139 |
BRADYCARDIA |
20 |
0.0004 |
| 140 |
PREMATURE DELIVERY |
6 |
0.0004 |
| 141 |
AREFLEXIA |
1 |
0.0004 |
| 142 |
MYASTHENIA GRAVIS |
3 |
0.0004 |
| 143 |
MYOCARDITIS |
4 |
0.0003 |
| 144 |
PARAPLEGIA |
1 |
0.0003 |
| 145 |
HAEMOTHORAX |
1 |
0.0003 |
| 146 |
PRODUCT LABEL CONFUSION |
2 |
0.0003 |
| 147 |
COVID-19 PNEUMONIA |
4 |
0.0003 |
| 148 |
HEPATITIS CHOLESTATIC |
2 |
0.0003 |
| 149 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
1 |
0.0003 |
| 150 |
SUPRAVENTRICULAR TACHYCARDIA |
3 |
0.0003 |
| 151 |
VENTRICULAR HYPOKINESIA |
1 |
0.0003 |
| 152 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
17 |
0.0003 |
| 153 |
INCOHERENT |
2 |
0.0003 |
| 154 |
FIBRIN D DIMER INCREASED |
1 |
0.0003 |
| 155 |
HAEMORRHAGIC DIATHESIS |
1 |
0.0003 |
| 156 |
VISUAL FIELD DEFECT |
2 |
0.0003 |
| 157 |
REBOUND EFFECT |
3 |
0.0003 |
| 158 |
CAESAREAN SECTION |
3 |
0.0003 |
| 159 |
ORAL HERPES |
5 |
0.0003 |
| 160 |
NEUROLEPTIC MALIGNANT SYNDROME |
3 |
0.0003 |
| 161 |
ATRIAL FLUTTER |
2 |
0.0003 |
| 162 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
1 |
0.0002 |
| 163 |
PERIPHERAL ISCHAEMIA |
1 |
0.0002 |
| 164 |
RESPIRATORY DEPRESSION |
3 |
0.0002 |
| 165 |
POLYURIA |
2 |
0.0002 |
| 166 |
ANAPHYLACTOID REACTION |
1 |
0.0002 |
| 167 |
COAGULOPATHY |
4 |
0.0002 |
| 168 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
4 |
0.0002 |
| 169 |
ARRHYTHMIA |
11 |
0.0002 |
| 170 |
CARDIAC ARREST |
19 |
0.0002 |
| 171 |
RHINITIS ALLERGIC |
1 |
0.0002 |
| 172 |
TACHYPNOEA |
3 |
0.0002 |
| 173 |
PULSE ABSENT |
1 |
0.0002 |
| 174 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
0.0002 |
| 175 |
CEREBRAL ISCHAEMIA |
1 |
0.0002 |
| 176 |
BLOOD LACTIC ACID INCREASED |
1 |
0.0002 |
| 177 |
INTERVERTEBRAL DISC PROTRUSION |
4 |
0.0002 |
| 178 |
DRUG LEVEL INCREASED |
3 |
0.0002 |
| 179 |
INTRACRANIAL PRESSURE INCREASED |
1 |
0.0002 |
| 180 |
NEPHROPATHY TOXIC |
2 |
0.0002 |
| 181 |
MYOCARDIAL ISCHAEMIA |
2 |
0.0002 |
| 182 |
HYPERVENTILATION |
1 |
0.0002 |
| 183 |
CARDIAC PACEMAKER INSERTION |
1 |
0.0002 |
| 184 |
DIABETIC KETOACIDOSIS |
4 |
0.0002 |
| 185 |
PREMATURE BABY |
5 |
0.0002 |
| 186 |
EXPOSURE DURING PREGNANCY |
10 |
0.0002 |
| 187 |
METABOLIC ACIDOSIS |
5 |
0.0002 |
| 188 |
MYDRIASIS |
2 |
0.0002 |
| 189 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
4 |
0.0002 |
| 190 |
POST-TRAUMATIC STRESS DISORDER |
1 |
0.0001 |
| 191 |
WRONG PRODUCT ADMINISTERED |
1 |
0.0001 |
| 192 |
BONE MARROW FAILURE |
3 |
0.0001 |
| 193 |
DRUG INTERACTION |
23 |
0.0001 |
| 194 |
ENCEPHALITIS |
1 |
0.0001 |
| 195 |
ATRIAL FIBRILLATION |
14 |
0.0001 |
| 196 |
EXTRASYSTOLES |
1 |
0.0001 |
| 197 |
DUODENAL ULCER |
1 |
0.0001 |
| 198 |
DIALYSIS |
2 |
0.0001 |
| 199 |
SUBDURAL HAEMATOMA |
2 |
0.0001 |
| 200 |
MATERNAL DRUGS AFFECTING FOETUS |
1 |
0.0001 |
| 201 |
SHOCK |
3 |
0.0001 |
| 202 |
PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 203 |
BRONCHOPULMONARY ASPERGILLOSIS |
1 |
0.0001 |
| 204 |
EJECTION FRACTION DECREASED |
2 |
0.0001 |
| 205 |
APNOEA |
1 |
0.0001 |
| 206 |
CYANOSIS |
2 |
0.0001 |
| 207 |
PNEUMOTHORAX |
2 |
0.0001 |
| 208 |
COMA |
6 |
0.0001 |
| 209 |
INTENTIONAL OVERDOSE |
8 |
0.0001 |
| 210 |
TOXICITY TO VARIOUS AGENTS |
21 |
0.0001 |
| 211 |
BLOOD POTASSIUM INCREASED |
2 |
0.0001 |
| 212 |
CEREBRAL INFARCTION |
3 |
0.0001 |
| 213 |
PNEUMONIA ASPIRATION |
3 |
0.0001 |
| 214 |
DRUG USE DISORDER |
1 |
0.0001 |
| 215 |
CIRCULATORY COLLAPSE |
2 |
0.0001 |
| 216 |
MYOPATHY |
1 |
0.0001 |
| 217 |
NEUROTOXICITY |
2 |
0.0001 |
| 218 |
HEART RATE DECREASED |
4 |
0.0001 |
| 219 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
2 |
0.0001 |
| 220 |
WRONG DRUG ADMINISTERED |
1 |
0.0001 |
| 221 |
ISCHAEMIC STROKE |
2 |
0.0001 |
| 222 |
MYOSITIS |
1 |
0.0001 |
| 223 |
BLOOD BILIRUBIN INCREASED |
3 |
0.0001 |
| 224 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 225 |
TREATMENT FAILURE |
9 |
0.0001 |
| 226 |
POISONING DELIBERATE |
1 |
0.0001 |
| 227 |
INTERNATIONAL NORMALISED RATIO INCREASED |
3 |
0.0001 |
| 228 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
4 |
0.0001 |
| 229 |
HAEMATOCRIT DECREASED |
2 |
0.0001 |
| 230 |
HYPOTONIA |
1 |
0.0001 |
| 231 |
BRAIN INJURY |
1 |
0.0001 |
| 232 |
APHASIA |
3 |
0.0001 |
| 233 |
DRUG LEVEL DECREASED |
1 |
0.0001 |
| 234 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
1 |
0.0001 |
| 235 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 236 |
PULMONARY HYPERTENSION |
2 |
0.0001 |
| 237 |
RESPIRATORY FAILURE |
7 |
0.0001 |
| 238 |
HYPOTENSION |
19 |
0.0001 |
| 239 |
ACUTE KIDNEY INJURY |
14 |
0.0001 |
| 240 |
DRUG INEFFECTIVE |
120 |
0.0001 |
| 241 |
TOOTH FRACTURE |
1 |
0.0001 |
| 242 |
THERAPY NON-RESPONDER |
4 |
0.0001 |
| 243 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 244 |
HYPOXIA |
3 |
0.0001 |
| 245 |
ATAXIA |
1 |
0.0001 |
| 246 |
CHOLECYSTITIS |
1 |
0.0001 |
| 247 |
OVERDOSE |
18 |
0.0001 |
| 248 |
ILEUS |
1 |
0.0001 |
| 249 |
BRAIN OEDEMA |
1 |
0.0001 |
| 250 |
DRUG RESISTANCE |
2 |
0.0001 |
| 251 |
HAEMATOMA |
2 |
0.0001 |
| 252 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 253 |
SINUS CONGESTION |
1 |
0.0001 |
| 254 |
DRUG TOXICITY |
1 |
0.0001 |
| 255 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 256 |
HYPOMAGNESAEMIA |
1 |
0.0001 |
| 257 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 258 |
RENAL FAILURE ACUTE |
3 |
0.0001 |
| 259 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
2 |
0.0001 |
| 260 |
PARALYSIS |
1 |
0.0001 |
| 261 |
HYPOKINESIA |
1 |
0.0001 |
| 262 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 263 |
MATERNAL EXPOSURE DURING PREGNANCY |
6 |
0.0001 |
| 264 |
THYROID DISORDER |
1 |
0.0001 |
| 265 |
LUNG INFECTION |
1 |
0.0001 |
| 266 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 267 |
DRUG-INDUCED LIVER INJURY |
2 |
0.0001 |
| 268 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 269 |
HYPOTHYROIDISM |
2 |
0.0001 |
| 270 |
LACTIC ACIDOSIS |
2 |
0.0001 |
| 271 |
FOETAL EXPOSURE DURING PREGNANCY |
5 |
0.0001 |
| 272 |
SEIZURE |
7 |
0.0001 |
| 273 |
PRODUCT USE IN UNAPPROVED INDICATION |
15 |
0.0001 |
| 274 |
SYNCOPE |
6 |
0.0001 |
| 275 |
PERICARDITIS |
1 |
0.0001 |
| 276 |
CONDITION AGGRAVATED |
18 |
0.0001 |
| 277 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 278 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 279 |
HYPERKALAEMIA |
2 |
0.0001 |
| 280 |
PANCREATITIS |
3 |
0.0001 |
| 281 |
CEREBRAL HAEMORRHAGE |
2 |
0.0001 |
| 282 |
AGRANULOCYTOSIS |
1 |
0.0001 |
| 283 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 284 |
HEPATIC FUNCTION ABNORMAL |
2 |
0.0001 |
| 285 |
FRACTURE |
1 |
0.0001 |
| 286 |
RENAL FAILURE |
7 |
0.0001 |
| 287 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 288 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 289 |
DISORIENTATION |
2 |
0.0001 |
| 290 |
PREGNANCY |
1 |
0.0000 |
| 291 |
OEDEMA PERIPHERAL |
6 |
0.0000 |
| 292 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 293 |
DRUG ABUSE |
4 |
0.0000 |
| 294 |
RHABDOMYOLYSIS |
2 |
0.0000 |
| 295 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 296 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 297 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 298 |
INTENTIONAL PRODUCT MISUSE |
4 |
0.0000 |
| 299 |
OFF LABEL USE |
40 |
0.0000 |
| 300 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 301 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 302 |
DEVICE MALFUNCTION |
3 |
0.0000 |
| 303 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 304 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 305 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 306 |
JOINT SWELLING |
5 |
0.0000 |
| 307 |
INTERSTITIAL LUNG DISEASE |
2 |
0.0000 |
| 308 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 309 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 310 |
PRESYNCOPE |
1 |
0.0000 |
| 311 |
NEURALGIA |
1 |
0.0000 |
| 312 |
AGITATION |
3 |
0.0000 |
| 313 |
LIVER INJURY |
1 |
0.0000 |
| 314 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 315 |
CHRONIC KIDNEY DISEASE |
3 |
0.0000 |
| 316 |
HEPATITIS |
1 |
0.0000 |
| 317 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 318 |
PLATELET COUNT DECREASED |
4 |
0.0000 |
| 319 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 320 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 321 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 322 |
OXYGEN SATURATION DECREASED |
2 |
0.0000 |
| 323 |
HERPES ZOSTER |
2 |
0.0000 |
| 324 |
DRUG WITHDRAWAL SYNDROME |
3 |
0.0000 |
| 325 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 326 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 327 |
HEPATIC FAILURE |
1 |
0.0000 |
| 328 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 329 |
HEART RATE INCREASED |
3 |
0.0000 |
| 330 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 331 |
ABDOMINAL DISCOMFORT |
5 |
0.0000 |
| 332 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 333 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 334 |
THROMBOCYTOPENIA |
3 |
0.0000 |
| 335 |
BLOOD PRESSURE INCREASED |
4 |
0.0000 |
| 336 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 337 |
CARDIAC FAILURE |
2 |
0.0000 |
| 338 |
CARDIAC FAILURE CONGESTIVE |
2 |
0.0000 |
| 339 |
THROMBOSIS |
2 |
0.0000 |
| 340 |
GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0000 |
| 341 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 342 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 343 |
WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 344 |
LOSS OF CONSCIOUSNESS |
3 |
0.0000 |
| 345 |
SEPTIC SHOCK |
1 |
0.0000 |
| 346 |
MENTAL DISORDER |
1 |
0.0000 |
| 347 |
MYOCARDIAL INFARCTION |
4 |
0.0000 |
| 348 |
LIVER DISORDER |
1 |
0.0000 |
| 349 |
TINNITUS |
1 |
0.0000 |
| 350 |
HYPOKALAEMIA |
1 |
0.0000 |
| 351 |
WEIGHT DECREASED |
6 |
0.0000 |
| 352 |
CARDIAC DISORDER |
2 |
0.0000 |
| 353 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 354 |
CONTUSION |
2 |
0.0000 |
| 355 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 356 |
DYSPNOEA |
11 |
0.0000 |
| 357 |
NERVOUSNESS |
1 |
0.0000 |
| 358 |
CONFUSIONAL STATE |
3 |
0.0000 |
| 359 |
OEDEMA |
1 |
0.0000 |
| 360 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 361 |
TREMOR |
3 |
0.0000 |
| 362 |
WEIGHT INCREASED |
4 |
0.0000 |
| 363 |
HYPONATRAEMIA |
1 |
0.0000 |
| 364 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 365 |
CONVULSION |
1 |
0.0000 |
| 366 |
PALPITATIONS |
2 |
0.0000 |
| 367 |
CHILLS |
2 |
0.0000 |
| 368 |
DISEASE PROGRESSION |
2 |
0.0000 |
| 369 |
WHEEZING |
1 |
0.0000 |
| 370 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 371 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 372 |
PRODUCT USE ISSUE |
3 |
0.0000 |
| 373 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 374 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 375 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 376 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 377 |
DEHYDRATION |
2 |
0.0000 |
| 378 |
PYREXIA |
5 |
0.0000 |
| 379 |
INJURY |
1 |
0.0000 |
| 380 |
HYPERTENSION |
3 |
0.0000 |
| 381 |
EPISTAXIS |
1 |
0.0000 |
| 382 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 383 |
TACHYCARDIA |
1 |
0.0000 |
| 384 |
CHEST PAIN |
2 |
0.0000 |
| 385 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 386 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 387 |
FLUSHING |
1 |
0.0000 |
| 388 |
SINUSITIS |
1 |
0.0000 |
| 389 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 390 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 391 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 392 |
SEPSIS |
1 |
0.0000 |
| 393 |
DIZZINESS |
4 |
0.0000 |
| 394 |
HYPERHIDROSIS |
1 |
0.0000 |
| 395 |
NAUSEA |
6 |
0.0000 |
| 396 |
VISION BLURRED |
1 |
0.0000 |
| 397 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 398 |
VOMITING |
3 |
0.0000 |
| 399 |
HEADACHE |
4 |
0.0000 |
| 400 |
DRUG DEPENDENCE |
1 |
0.0000 |
| 401 |
PNEUMONIA |
2 |
0.0000 |
| 402 |
FALL |
2 |
0.0000 |
| 403 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 404 |
MUSCLE SPASMS |
1 |
0.0000 |
| 405 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 406 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 407 |
ANAEMIA |
1 |
0.0000 |
| 408 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 409 |
MALAISE |
2 |
0.0000 |
| 410 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 411 |
BACK PAIN |
1 |
0.0000 |
| 412 |
FEELING ABNORMAL |
1 |
0.0000 |
| 413 |
PRURITUS |
1 |
0.0000 |
| 414 |
FATIGUE |
2 |
0.0000 |
| 415 |
ARTHRALGIA |
1 |
0.0000 |
| 416 |
DEATH |
2 |
0.0000 |
| 417 |
RASH |
1 |
0.0000 |
| 418 |
DIARRHOEA |
1 |
0.0000 |